Paper: Evolution of the Brazilian Drug Control System: Case Study of ADB-FUBIATA, a Psychotropic NPS

December 2024 Introduction The New Psychoactive Substances (NPS) market is very dynamic, requiring new legislative approaches to tackle the drug problem. Brazil has improved the Drug Scheduling System, making the process more agile, which allows fast scheduling of NPS. The Working Group conceived between Anvisa and the Ministry of Justice, brings together experts of health […]